+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 160 Pages
  • May 2023
  • Region: Global
  • GlobalData
  • ID: 5823119
The publisher's Medical Devices sector report, 'Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Neurosurgical Products pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Neurosurgical Products comprises of Dura Substitutes, Neuroendoscopes and Neurosurgical Drills.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Neurosurgical Products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Neurosurgical Products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Neurosurgical Products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Neurosurgical Products Overview
3 Products under Development
3.1 Neurosurgical Products - Pipeline Products by Stage of Development
3.2 Neurosurgical Products - Pipeline Products by Segment
3.3 Neurosurgical Products - Pipeline Products by Territory
3.4 Neurosurgical Products - Pipeline Products by Regulatory Path
3.5 Neurosurgical Products - Pipeline Products by Estimated Approval Date
3.6 Neurosurgical Products - Ongoing Clinical Trials
4 Neurosurgical Products - Pipeline Products under Development by Companies
4.1 Neurosurgical Products Companies - Pipeline Products by Stage of Development
4.2 Neurosurgical Products - Pipeline Products by Stage of Development
5 Neurosurgical Products Companies and Product Overview6 Neurosurgical Products- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Neurosurgical Products - Pipeline Products by Stage of Development
  • Neurosurgical Products - Pipeline Products by Segment
  • Neurosurgical Products - Pipeline Products by Territory
  • Neurosurgical Products - Pipeline Products by Regulatory Path
  • Neurosurgical Products - Pipeline Products by Estimated Approval Date
  • Neurosurgical Products - Ongoing Clinical Trials
  • Neurosurgical Products Companies - Pipeline Products by Stage of Development
  • Neurosurgical Products - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Neurosurgical Products - Pipeline Products by Stage of Development
  • Neurosurgical Products - Pipeline Products by Segment
  • Neurosurgical Products - Pipeline Products by Territory
  • Neurosurgical Products - Pipeline Products by Regulatory Path
  • Neurosurgical Products - Pipeline Products by Estimated Approval Date
  • Neurosurgical Products - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alcyone Therapeutics Inc
  • Aleva Neurotherapeutics SA
  • Anatomics Pty Ltd
  • Augusta University
  • Axion BioSystems Inc
  • AxoGen Corp
  • Beijing Biosis Healing Biological Technology Co Ltd
  • Bendit Technologies Ltd
  • Biocircuit Technologies Inc
  • C2C Development, LLC
  • Carnegie Mellon University
  • Carthera SAS
  • Cizeta Surgical
  • Cornell University
  • Elite Surgical Supplies (Pty) Ltd
  • Harvard University
  • Imperial College London
  • InSightec Ltd
  • Integra LifeSciences Holdings Corp
  • International HIFU
  • InVivo Therapeutics Corp
  • JetGuide Ltd
  • Johns Hopkins University
  • KARL STORZ SE & Co KG
  • Kerecis ehf
  • Kuros Biosciences AG
  • LeMaitre Vascular Inc
  • Lumendo AG
  • Massachusetts Institute of Technology
  • Mayo Clinic
  • Medtronic Plc
  • Microsurgical Innovations Inc
  • MRC Systems GmbH
  • Nanonerve Inc.
  • Neuraptive Therapeutics Inc
  • NeuroOne Medical Technologies Corp
  • Nurami Medical Ltd
  • Orthocell Ltd
  • PediaWorks Inc
  • Replication Medical Inc
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Scivita Medical Technology Co Ltd
  • Senzime AB
  • Skull Base Institute
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • The Swedish Neuroscience Institute
  • U.S. Department of Veterans Affairs
  • University of Colorado
  • University of Maryland Baltimore
  • University of South Florida
  • University of Texas Medical Branch at Galveston
  • University of Utah
  • Vanderbilt University
  • Xylos Corporation